Source:http://linkedlifedata.com/resource/pubmed/id/19577301
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
15
|
pubmed:dateCreated |
2009-8-24
|
pubmed:abstractText |
The present study analyzed the immunomodulatory potential of a newly identified duck beta-defensin, Apl_AvBD2. Recombinant Apl_AvBD2 expressed in HEK293T cells induced a concentration dependent in vitro migration of duck splenocytes, and spleen B- and T-lymphocytes, which was specifically inhibited by anti-Apl_AvBD2 polyclonal antibodies. Among the transcripts of 13 immunologically important genes analyzed in cultured splenocytes for the early immunomodulatory effect of Apl_AvBD2, dendritic cell immunoreceptor (DCIR) mRNA was found to be significantly down-regulated. However, there were no major changes in the expression levels of transcripts for cell surface proteins (MHC I, MHC II 2 beta-chain, TCR-beta, TLR-7, DCAR, CD44, and CD58) and cytokines (IL-2, IFN-gamma, RANTES, MIP-1beta-like and MCP-1 like chemokines). Our results reveal chemotactic and immunomodulatory properties of Apl_AvBD2, two important functions that would help in employing this protein as a molecular adjuvant with avian vaccines.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Influenza Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Lectins, C-Type,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Immunologic,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Defensins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1872-9142
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3070-5
|
pubmed:meshHeading |
pubmed-meshheading:19577301-Adjuvants, Immunologic,
pubmed-meshheading:19577301-Animals,
pubmed-meshheading:19577301-B-Lymphocytes,
pubmed-meshheading:19577301-Chemotaxis,
pubmed-meshheading:19577301-Cytokines,
pubmed-meshheading:19577301-Dendritic Cells,
pubmed-meshheading:19577301-Ducks,
pubmed-meshheading:19577301-Humans,
pubmed-meshheading:19577301-Influenza Vaccines,
pubmed-meshheading:19577301-Lectins, C-Type,
pubmed-meshheading:19577301-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:19577301-RNA, Messenger,
pubmed-meshheading:19577301-Receptors, Immunologic,
pubmed-meshheading:19577301-Recombinant Proteins,
pubmed-meshheading:19577301-T-Lymphocytes,
pubmed-meshheading:19577301-beta-Defensins
|
pubmed:year |
2009
|
pubmed:articleTitle |
Immunomodulation by duck defensin, Apl_AvBD2: in vitro dendritic cell immunoreceptor (DCIR) mRNA suppression, and B- and T-lymphocyte chemotaxis.
|
pubmed:affiliation |
Molecular Virology Laboratory, Department of Molecular Microbiology, Rajiv Gandhi Centre for Biotechnology (RGCB), Thycaud PO, Thiruvananthapuram 695014, Kerala, India.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|